It is possible that obesity contributes to the generation of both anti-TPO and anti-TG autoantibodies, although experimental models have led to the hypothesis that the production of anti-TG may occur earlier, followed by the development of anti-TPO [81,84,85]. The gene discussed is TG; the disease is obesity disorder.